Concepts (110)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Percutaneous Coronary Intervention | 7 | 2019 | 225 | 2.180 |
Why?
|
| Product Surveillance, Postmarketing | 4 | 2020 | 26 | 1.280 |
Why?
|
| Cardiac Catheterization | 3 | 2019 | 293 | 0.990 |
Why?
|
| Platelet Aggregation Inhibitors | 2 | 2017 | 235 | 0.900 |
Why?
|
| Drug-Eluting Stents | 4 | 2023 | 68 | 0.870 |
Why?
|
| Diffusion of Innovation | 2 | 2021 | 58 | 0.860 |
Why?
|
| Coronary Artery Disease | 3 | 2017 | 324 | 0.820 |
Why?
|
| Peripheral Arterial Disease | 3 | 2023 | 165 | 0.790 |
Why?
|
| Cardiovascular Diseases | 2 | 2021 | 863 | 0.720 |
Why?
|
| Hemodynamic Monitoring | 1 | 2021 | 2 | 0.720 |
Why?
|
| Remote Sensing Technology | 1 | 2021 | 6 | 0.710 |
Why?
|
| Atrial Pressure | 1 | 2021 | 6 | 0.710 |
Why?
|
| Eicosapentaenoic Acid | 1 | 2021 | 18 | 0.710 |
Why?
|
| Atrial Function, Left | 1 | 2021 | 32 | 0.700 |
Why?
|
| Arterial Pressure | 1 | 2021 | 27 | 0.700 |
Why?
|
| Glomerular Filtration Rate | 1 | 2021 | 120 | 0.670 |
Why?
|
| Pulmonary Artery | 1 | 2021 | 96 | 0.670 |
Why?
|
| Myocardial Infarction | 3 | 2017 | 919 | 0.660 |
Why?
|
| Equipment Safety | 2 | 2017 | 26 | 0.640 |
Why?
|
| Renal Artery | 1 | 2020 | 36 | 0.620 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2021 | 147 | 0.610 |
Why?
|
| Cardiac Catheters | 1 | 2019 | 13 | 0.580 |
Why?
|
| Coronary Angiography | 3 | 2018 | 212 | 0.580 |
Why?
|
| Registries | 4 | 2020 | 922 | 0.550 |
Why?
|
| Health Care Costs | 2 | 2022 | 223 | 0.530 |
Why?
|
| Radial Artery | 1 | 2018 | 55 | 0.530 |
Why?
|
| Diabetes Complications | 1 | 2017 | 106 | 0.510 |
Why?
|
| Atherosclerosis | 1 | 2018 | 163 | 0.490 |
Why?
|
| Aspirin | 1 | 2017 | 172 | 0.490 |
Why?
|
| Telemedicine | 1 | 2021 | 363 | 0.490 |
Why?
|
| Thrombectomy | 1 | 2019 | 254 | 0.490 |
Why?
|
| Postoperative Care | 1 | 2017 | 125 | 0.480 |
Why?
|
| Ulnar Artery | 1 | 2015 | 12 | 0.460 |
Why?
|
| Heart Arrest | 1 | 2017 | 175 | 0.430 |
Why?
|
| Precision Medicine | 1 | 2016 | 129 | 0.430 |
Why?
|
| Hypertension | 1 | 2020 | 612 | 0.420 |
Why?
|
| Hospitals | 1 | 2017 | 386 | 0.410 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 2015 | 102 | 0.410 |
Why?
|
| Quality Indicators, Health Care | 1 | 2017 | 346 | 0.400 |
Why?
|
| Heart Failure | 1 | 2021 | 954 | 0.400 |
Why?
|
| Catheter Ablation | 1 | 2015 | 156 | 0.380 |
Why?
|
| Humans | 22 | 2023 | 65124 | 0.360 |
Why?
|
| Physicians | 1 | 2017 | 477 | 0.350 |
Why?
|
| Equipment Design | 4 | 2021 | 363 | 0.350 |
Why?
|
| Cardiovascular Agents | 2 | 2023 | 106 | 0.340 |
Why?
|
| Treatment Outcome | 8 | 2023 | 5788 | 0.300 |
Why?
|
| Atrial Fibrillation | 1 | 2015 | 879 | 0.240 |
Why?
|
| Endovascular Procedures | 2 | 2023 | 626 | 0.200 |
Why?
|
| Angioplasty, Balloon | 1 | 2021 | 55 | 0.170 |
Why?
|
| Male | 8 | 2021 | 31042 | 0.170 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2021 | 99 | 0.170 |
Why?
|
| Female | 8 | 2021 | 34016 | 0.160 |
Why?
|
| Denervation | 1 | 2020 | 18 | 0.160 |
Why?
|
| Feasibility Studies | 2 | 2020 | 587 | 0.160 |
Why?
|
| Prospective Studies | 4 | 2021 | 3310 | 0.150 |
Why?
|
| Prosthesis Failure | 1 | 2020 | 78 | 0.150 |
Why?
|
| Double-Blind Method | 1 | 2021 | 739 | 0.150 |
Why?
|
| Patient Safety | 2 | 2020 | 259 | 0.150 |
Why?
|
| Electric Countershock | 1 | 2020 | 105 | 0.150 |
Why?
|
| Equipment Failure | 1 | 2019 | 63 | 0.140 |
Why?
|
| Predictive Value of Tests | 1 | 2021 | 1113 | 0.140 |
Why?
|
| Antihypertensive Agents | 1 | 2020 | 179 | 0.140 |
Why?
|
| Aged | 5 | 2022 | 14958 | 0.140 |
Why?
|
| Natriuretic Peptides | 1 | 2018 | 9 | 0.140 |
Why?
|
| Troponin | 1 | 2018 | 39 | 0.140 |
Why?
|
| Medicare | 1 | 2022 | 624 | 0.130 |
Why?
|
| Kidney | 1 | 2020 | 451 | 0.130 |
Why?
|
| Risk Assessment | 3 | 2020 | 2102 | 0.130 |
Why?
|
| Vascular Access Devices | 1 | 2017 | 15 | 0.130 |
Why?
|
| Coronary Artery Bypass | 1 | 2019 | 292 | 0.130 |
Why?
|
| United States Food and Drug Administration | 1 | 2017 | 90 | 0.130 |
Why?
|
| Vascular Closure Devices | 1 | 2017 | 6 | 0.130 |
Why?
|
| New York | 1 | 2017 | 144 | 0.130 |
Why?
|
| Reproducibility of Results | 1 | 2021 | 1698 | 0.130 |
Why?
|
| Prognosis | 1 | 2021 | 1785 | 0.130 |
Why?
|
| Middle Aged | 5 | 2021 | 18267 | 0.130 |
Why?
|
| Defibrillators, Implantable | 1 | 2020 | 273 | 0.120 |
Why?
|
| Intracranial Hemorrhages | 1 | 2017 | 69 | 0.120 |
Why?
|
| Drug Administration Schedule | 1 | 2017 | 296 | 0.120 |
Why?
|
| Coronary Vessels | 1 | 2017 | 125 | 0.120 |
Why?
|
| Tissue Plasminogen Activator | 1 | 2017 | 126 | 0.120 |
Why?
|
| Algorithms | 1 | 2021 | 1048 | 0.120 |
Why?
|
| Shock, Cardiogenic | 1 | 2017 | 108 | 0.120 |
Why?
|
| Fibrinolytic Agents | 1 | 2017 | 178 | 0.120 |
Why?
|
| Thrombolytic Therapy | 1 | 2017 | 195 | 0.120 |
Why?
|
| Drug Therapy, Combination | 1 | 2017 | 463 | 0.110 |
Why?
|
| Pulmonary Embolism | 1 | 2017 | 196 | 0.110 |
Why?
|
| Biomarkers | 1 | 2018 | 1480 | 0.090 |
Why?
|
| Popliteal Artery | 2 | 2023 | 24 | 0.090 |
Why?
|
| Vascular Patency | 2 | 2023 | 134 | 0.090 |
Why?
|
| Paclitaxel | 2 | 2023 | 102 | 0.090 |
Why?
|
| Femoral Artery | 2 | 2023 | 104 | 0.090 |
Why?
|
| Multicenter Studies as Topic | 1 | 2021 | 159 | 0.040 |
Why?
|
| Prosthesis Design | 1 | 2020 | 219 | 0.040 |
Why?
|
| Risk Factors | 2 | 2020 | 5429 | 0.030 |
Why?
|
| United States | 2 | 2022 | 8097 | 0.030 |
Why?
|
| Anticoagulants | 1 | 2022 | 525 | 0.030 |
Why?
|
| Fatal Outcome | 1 | 2017 | 122 | 0.030 |
Why?
|
| Risk | 1 | 2017 | 374 | 0.030 |
Why?
|
| Computed Tomography Angiography | 1 | 2017 | 140 | 0.030 |
Why?
|
| Population Surveillance | 1 | 2017 | 210 | 0.030 |
Why?
|
| Ultrasonography, Interventional | 1 | 2017 | 123 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2021 | 2619 | 0.030 |
Why?
|
| Hemorrhage | 1 | 2017 | 285 | 0.030 |
Why?
|
| Tomography, Optical Coherence | 1 | 2017 | 235 | 0.030 |
Why?
|
| Echocardiography | 1 | 2017 | 510 | 0.030 |
Why?
|
| Incidence | 1 | 2017 | 1418 | 0.020 |
Why?
|
| Time Factors | 1 | 2020 | 3762 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2022 | 6862 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2017 | 5612 | 0.020 |
Why?
|